Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to ...

Comox's Aurora Cannabis Inc., has announced the company’s discovery of a novel source of genetic resistance against powdery ...

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, ...

Shares of Aurora Cannabis Inc. ACB rallied 5.30% to $4.57 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.33% to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Aurora Cannabis announces breakthrough discovery of powdery mildew-resistant cultivars, providing a critical solution to a pressing challenge in the cannabis industry. This research could lead to ...

Aurora shares are trading higher on Thursday after the company announced it discovered a novel source of genetic resistance against powdery mildew.

Aurora Cannabis (TSX:ACB) announced the discovery of PM2, a new source of genetic resistance for cannabis plants against ...

Announced the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that pr ...

Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...

Aurora Cannabis capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics, and deep regulatory knowledge to expand ...